9,10-dimethyl-1,2-benzanthracene has been researched along with gw9662 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glazer, RI; Kopelovich, L; Lu, J; Yin, Y; Yuan, H | 1 |
Alimirah, F; Hawthorne, M; Kalra, A; Kopelovich, L; Mehta, RG; Mehta, RR; Peng, X; Roy, S | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and gw9662
Article | Year |
---|---|
Drug-targeted inhibition of peroxisome proliferator-activated receptor-gamma enhances the chemopreventive effect of anti-estrogen therapy.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Anilides; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinogens; Carcinoma; Chemoprevention; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Experimental; Mice; Microarray Analysis; Molecular Targeted Therapy; PPAR gamma | 2012 |
PPARĪ³ antagonist GW9662 induces functional estrogen receptor in mouse mammary organ culture: potential translational significance.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Anilides; Animals; Anticarcinogenic Agents; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Oxazoles; PPAR gamma; Precancerous Conditions; Receptors, Progesterone; Tamoxifen; Tissue Culture Techniques; Transcriptional Activation; Tyrosine | 2013 |